Assist. Prof. Zeynep Güral is a radiation oncologist with a strong clinical and academic background. She graduated from Istanbul University Faculty of Medicine in 2009 with specialization in Radiation Oncology. Since 2014 she has been part of the Acibadem Health Group, where she provides patient-centered radiotherapy care and participates in multidisciplinary cancer management. Her professional interests include neuro-oncology and thoracic malignancies. She is an active member of the Society of Neuro-Oncology, the Turkish Society of Radiation Oncology, the European Society for Radiotherapy and Oncology (ESTRO), and the Lung Cancer Association, contributing to both national and international knowledge exchange and best practices in cancer treatment.
Education
- 2009 Istanbul University Istanbul Faculty of Medicine Radiation Oncology
- 2003 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2014 Acibadem Health Group
- 2012 – 2014 Bezmialem Foundation University / Lecturer
- 2010 – 2012 Balıkesir State Hospital / Specialist Doctor
- 2009 AMC,Amsterdam-Netherlands / Clinical Observer
Memberships
- Society of Neurooncology
- Turkish Society of Radiation Oncology
- European Society for Therapeutic Radiology and Oncology (ESTRO)
- Lung Cancer Association
Publications
- Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup.
Yucel S, Zekri J, Oyan B. Breast. 2014 Jun 27. pii: S0960-9776(14)00096-4. doi: 10.1016/j.breast.2014.05.023. [Epub ahead of print] Rordorf T,Hassan AA,Azim H,Alexandru E,Er O,Gokmen E,Güral Z,Mardiak J,Minchev V,Peintinger F,Szendroi M,Takac I,Tesarova P,Vorobiof D,Vrbanec D, - Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.
Cancer Chemother Pharmacol. 2014 Aug 8. [Epub ahead of print] Akgun Z, Saglam S, Yucel S, Gural Z, Balik E, Cipe G, Yildiz S, Kilickap S, Okyar A, Kaytan-Saglam E. - Does early PET/CT assesment of response to chemotherapy predicts survival in patients with advanced stage non-small-cell lung cancer?
Medicine (Baltimore). 2014 Dec;93(28):e299 Ordu C , Selcuk NA, Erdogan E, Angin G, Gural Z, Memis H, Yencilek E, Dalsuna S, Pilanci K. - Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?
Med Oncol. 2013 Sep;30(3):660 Kilic L, Ordu C, Ekenel M, Yildiz I, Keskin S, Sen F, Gural Z, Asoglu O, Kizir A, Aykan F. - Skin Recurrence of a Phyllodes Tumor and Impact of Radiotherapy: A Case Report and Review of the Literature.
Journal of Cancer Research Updates, 2013, 2, 131-134 5. Serap Yücel, Hüseyin Kadıoglu, Zeynep Güral, Şeyma Yıldız and Zuhal Gücin - Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?
Diagn Diagn Interv Radiol. 2012 Nov-Dec;18(6):574-81. Engin G, Sharifov R, Güral Z, Sağlam EK, Sağlam S, Balik E, Asoğu O, Yamaner S, Güllüoğu M, Kapran Y, Özel S. - Primary Breast Lymphoma; Recurrent Disease
Mahmut Muslimoğlu, Esra Kaytan Sağlam Turkish Journal of Oncology (2012) 27: 88-92 Hüseyin Kadıoğlu, Serap Yücel, Zeynep GÜRAL, Nurhan Gözübüyükoğlu, Züleyha Akgün, Şeyma Yıldız, Zuhal Gülcin, Süleyman Bozkurt, Yeliz Emine Ersoy,
